changes in the ratio of urina工yα1-microglobulin to ulinastatin
TRANSCRIPT
T. Inagaki et al.
mer’s disease. Prag ;・481-495.et al. Receptors for
>ping and neuron昌l
13: 21-30. oa L et al. Bram
vascular dementia.
41-151. ~ R et al. Structural
,r light-chain gene.
Is and cort1cotrop1c
>Sin l出 ibitor(and
:of. 1962; 19: 293-
.an unna可 trypsin
iver. LφSci. 1992;
Changes in the Ratio of Urina工yα1-Microglobulin to Ulinastatin
Levels in Patien七S wi七hPsychiatric Diseases
Takuj i 工nagaki, Tadahiro Shikimi, Akihiko Fujimoto, Hi工oshi
Ishino, Hideki Okunishi, and Shuji Takaori
Department of Psych工atry (TI, AF, HI) and Department of
Pha工macology (TS' HO' ST)' Sh工mane Medical Uni ve工sity F 工zumo,
Shimane 693, Japan
1
I n七工oduc七工on
Alpha-1-Mic工oglobulin (αlM, 3 lkDa) and ulinastatin安(UT, 40kDa)
in human u工ine are derived f工om a similar precurso工 protein in
the liver (Kaumeyer e七 al 1986). Hitherto, the physiologically
relevant functions of these substances have not been cla工ified.
The amino acid sequence of UT is no七 only highly homologous to
the inhibitory domain of amyloid 戸-p工otr~in precursor associated
with senile plaque or amyloid angiopathy ( Ki七agu七i et al 1988;
Ponte et al 1988; Tanzi et al 1988), bu七 aUT-like immunoreactive
substance with trypsin inhibi七ory activities is also found in
brain sites related to memory and lea工ning ( Shikimi et al 19 9 3)・
The relationships of u工inaryαlM andl UT levels have been
p工eviously found to differ between the dementia and aged-matched
con七工ol q工oups. In addition, diffe工ent patte工ns of αlM/UT ratio
in relation to the severity of dementia and dura七ion of the
disease have been displayed between Alzheime工-type senile
dementia and vascular dementia patients (Inagaki et al 1995). In
the present study, we studied further whE~ther or not the relation
between urinary levels of αlM and UT differed in patients with
psychoses.
合 The generic name of this human U工inary trypsin inhibi七or has
been recently changed from ur工nastat工n to ul工nas七at工n, as the
substance is found not only in urine but also in serum.
2
Methods
Twelve pa七ien七S with schizoph工enia and 19 pa七ients with mood
disorde工( 10, pat工ents with b工polar affective disorde工; 9I
patients with major dep工ession) we工e diagnosed according to the
DSM-III-R (American Psychiat工ic Association 1987)・ Patients ove工
60 yea工s of age we工e excluded in this study. The durations of
schizophrenia and mood diso工der in patients were 10. 4 ± 2. 3 and
6 . 1 ± 1. 8 years ( mean 士 S.E.M), respec七ively. The respective
severities of schizophrenia and mood disorder patients were 43 +
6 (Brief Psych工atryRat工ng Scale, Overall and Gorham 1962) and 24
± 4 points (Hamilton Depression Rating Scale, Hamilton 1960)(mean
±S.E.M)・ Patien七S with bipolar affective disorde工( 6 patients
with and 4 w工thout 1工th工um treatment for at least 4 months)
indicated neither manic nor dep工ess工ve E~pisodes for at leas七 30
days. All the patien七s wi七h majo工 dep工essionwe工e 七工eatedwith
antidep工essants. As age-matched cont工ols, 18 subjects withou七
any presen七 0工 pas七 h工story of psychia七工工c diseases we工e
included. None of the subjects indica七ed hepa七ic/工enal
dysfunctions or o七her malignan七 diseases. 工nfo工medconsent was
obtained from all subjects befo工ethe study.
Spontaneously collected urine (from the subjects) was
centrifuged a七 1,000 x g for 10 min at 4°C 七o remove debris and
amo工phous salts P工ior 七o storage at -50°C until assay. u工ina工Y
levels of αlM and UT were measured with EL工SA, whereby
galactosidase-labelled goat anti-rabbit IgG was interacted
3
(Biot工in 工nternational, Dublin) with rabb工七 anti-αlM 工gG (Dako
Co. , Copenhagen) and r abb工t ant工ーUT IgG (Sh工k工mi et al 19 9 O ) ,
工espectively. StandardαlM (Dako Co・F Copenhagen) and UT we工e
used as references. C工eatin工ne levels工nthe ur工newe工emeasured
with a photometric assay based on the Jaffe 工eaction (Wako
C工eatinine kit, Wako Chem工cals, Osaka)・ U工ina工y levels of αlM
and UT we工e expressed as μg /mg creatinine to co工工ect for the
dilution rate of urine samples.
Linear regression analyses were evaluated by us工ng the Sta七
View IV system (Abacus Concept,工nc., CA)・ Statistical
significance was verif工ed by the factor工al AN OVA followed by
Scheffe『s post hoc test.
statistically significant.
Results
Values where p<O. 05 were considered
In the bipolar affective disorder g工oup,, significant differences
in the age and urinary levels of creatinine FαlM and UT, and
αlM/UT 工atio we工e no七 detected between the li thium-t工ea七ed and
untreated patients. The lithium-treated and untreated patients
were thus pooled as a bipolar affect工ve d工sorder group. 工n the
Table 1, age and levels of creatinine, o.lM and UT did not diffe工
4
significantly among the cont工ol, schizoph工enia, mood diso工der
q工oups and 工ts subd工V工ded q工oups (b工pola工 affective disorder and
major dep工ession)・ The αlM/UT ratio of the mood diso工dergroup,
but not the sch工zophren工a group, was s.ignif icantly higher than
七ha七 of the cont工ols (P<O. 01)・ The bipolar affective disorder
patients, bu七 notthe ma〕ordepress工oncases, contr工butedto this
change.
Relating u工工nary levels of UT and αlM, a positive correlation
was obse工ved in the control, schizophrenia and mood diso工der
q工oups, acco工dingly (Fig. 1)・ A similar tendency was manifested
by the bipolar affective diso工der and major dep工ession groups
(Fig. 2)・ Although the regression slope of the schizoph工enia
cases was not S七atis七工cally d工ffe工ent f工om that of cont工ols, a
significan七 difference was no七ed between the mood disorde工 and
control g工oups (P<O. 05). Between the sch工zoph工enia and mood
disorder g工oups,七he regression slope was significantly ( P<O. 05)
differen七. Fur七hermore, the 工egress.ion slope of the majo工
depression q工oup, but not the bipola工 affective diso工der group,
was statistically ( P<O. 05) d工ffe工ent f工om those of con七工ols and
schizophrenia q工oups. 工n the schizoph工enia and mood diso工der
groups, neither the sco工es f工ompsychiat工ic ra七ing scales (B工ief
Psychiatric Rat工ng Scale and Hamil ton Dep工ession Rating Scale)
nor du工ations of disease correlated well with the U工inarylevels
of αlM O工 UT, orαlM/UT ratio.
5
Discussion
Comparing 七he schizophrenia and control q工oups, the工e were no
significant differences in the 工egression slopes, urinary levels
of αlM and UT, and αlM/UT 工atio. F'u工七hermore, neithe工 the
scores of Br工ef Psychiatric Ra七工ng Scale nor durations of 七he
diseases co工工elated well W工th 七he u工工nary levels of αlM or UT.
These findings sugges七七hat the urinary levels of αlM and UT and
αlM/UT 工atio are not influenced by the pathophysiology of
schizophrenia.
Comparing the mood disorder and control g工oups, the regression
slope of the former differed from that of controls. Within the
mood diso工der category, the slope of 七he maj o工 dep工ession group
was especially significant ( P<O. 0 5) . Furthe工mo工eF 七he αlM/UT
ratio of mood disorder was significantly ( P<O.01) higher than
that of controls. Within the mood diso工de工 catego工Y, the αlM/UT
工atio of the bipolar affective diso工der group was particularly
significan七 (P<0.01). These results suggest that the
工elationships between the urinary levels of αlM and UT in mood
disorder as a whole differ from those of cont工ols.
Comparing the mood diso工dercategory (and inclusive of bipolar
affec七ive diso工de工 and major depression) with schizophrenia
patients, the regression slopes of the mood disorde工 as a whole
6
and major dep工essionq工oupsdiffered f工omtha七 of schizophrenia.
工n our p工evious study (Inagaki e七 al 1995), a positive
co工relation between urina工y levels of αlM and UT has been
obse工ved in dementia patients. The 工espective regression slopes
of dementia q工oups (Alzhe工mer-type and vascular-type) we工e
significantly d工fferent from 七hat of non-dernen七ed con七工ols in
spite of insignificant difference in the αlM/UT ratio.
Therefore, the relat工on between ur工nary levels of αlM and UT
differed among the sch工zophren工a, mood d工so工der as a whole and
dementia pa七工ents.
The αlM/UT ratio of bipolar affec七ive disorder group was
significantly higher than 七hat of cont工ols. However, li thiurn
medication ( 6 0 毛 in the group we工e medicated with lithium) did
not affect the change. This was advocated by insignif ican七
differences in 七he urinary levels of creatinine FαlM and UT and
αlM/UT ratio between lithium-七工eated and untreated pa七ients.
With regard to diet, variations in the urinary levels of αlM and
UT and αlM/UT 工atio were not obse工ved. 工n addition, even in
patients wi七h uro工ogical diseases F七he regression slope rela七ing
to u工ina工y levels of αlM and UT remained statistically
insignificant f工omthat of heal七hysubjects (Shikirni et al 1994)・
Howeve工, thereg工essionslope of七hemood diso工de工 q工oupdiffered
from tha七 ofcont工ols. As none of the p工esentsubjects indicated
7
any renal dysfunctions F 工enalfactors cont工ibuting七ochanges in
the 工elation between urina工Y levels ofαlM and UT in mood
disorde工 patientsmay be discounted.
Glucoco工ticoid-responsive elements (Diarra-Mehrpour et al
1990) and interleukin 6 sequence motifs (Vetr and Gebhard 1990)
have been found in a gene of the αlM- and UT-de工ived precursor
protein. In addition, glucocorticoid-associated fluctuations of
UT in urine, in which plasma levels of glucocorticoids are
工eportedlyaffected by cytok工nes (Spolsky et al 1987; Hermus and
Sweep 19 9 0) , have been observed ( Faa工vang 1962). The urinary
levels of αlM, UT and αlM/UT ratio are also influenced by the
forms (free and complexed) of αlM and UT ex工st工ng工n plasma (αlM
and UT complexes respect工vely ex工st 工n IgA-complexed (Demars e七
al 1989) and IgG-complexed forms (Hochst工asser et al 1981)),
since only the free forms of these substances are found in u工ine
(Jonsson-Berling e七 al 1989; Demars et al 1989)・ Inthe e七iology
of psychosoc工ald工seasesF 七he 工mmunesystem has been focused as a
key facto工(Sm工th 1991)・ Changes 工n th12 system工c immune system,
neu工oimmune mechanisms in the cent工al nervous system and/or
cytokine concent工ations at pe工工pheral S工tes 工n psychoses may be
associated with the va工iable工elationships between u工inarylevels
of αlM and UT. Although七heexact mechanism(s) and physiological
significance of the αlM/UT 工atiowa工工antfu工therstudies, our
8
p工esen七 findings sugges七七hat a change in the relationship
be七ween Y
E
a
n
-- 工u
levels of αlM and UT 工efleets the
psychoneu工olog工cald工ffe工ences unde工ly工nsJthe various psychiatric
diseases in human.
9
Acknowledgements
The authors thank Dr. T. Sakura工(KonanHosp工tal, Shimane) and
colleagues 工n the Department of Psych工atry, Sh工mane Medical
university for providing 七he urine samples of subjects for this
study. Standard UT was a k工nd q工ft from Moch工da Pharmaceutical
Co・F Tokyo.
10
References
Ame工icanPsychiatr工C Associa七工on (1987): Diagnostic and
Sta七isticalManual of Mental Disorde工S' 3工ded, rev.
Washington DC: American Psychiatric Association.
Demars DD, Katzmann JA, K工ml工ngerTK, Calore JD, Tracy RP (1989):
Simultaneous measurement of total and工gA-conjugatedα1-
microglobulin by a combined immunoenzyme/immunoradiometric
assay technique. Cl工nChem 35:766-772.
Diarra-Meh工pourM, Bourguignon J, Sesbolie R, Salier J-P,
Leveillard T, Ma工七inJ-P (1990): St工uctu工alanalysis of the
human inter-α-trypsin inhibitor light-chain gene. Eu工 J
Biochem 191:131-139.
Faa工vangHJ (1962): The influence of glucocorticoids and
co工ticotropichormone on output of human u工ina工y trypsin
inhibitor (and hyaluronidase inhibi七O工) . Acta Pharmacol
Toxicol 19:293-304.
Hamilton M (1960): A 工atingscale for dep工ession. J Neu工ol
Neu工osu工gPsych工a七ry23:56-61.
He工musAR, Sweep CG (1990): Cy七okines and the hypothalamic-
pitui七ary-ad工enal axis. J Ste工oidBiochem Mol Biol 37:867-
871.
Hochst工asserK, Schonberger OL, Lempart K, Metzge工 M (1981):
Kunitz-type p工oteinase inhibito工S derived by limited
11
一三 也一一 一一一 一」
proteolysis of the inte工ーα-trypsininhibitor. VI. Detec七ionof
a complex between immunoglobul工n G and the inhibi七0工y active
par七 of the inte工ーα-tryps工n 工nh工bitor. Hoppe-Seyle工’ S z
Physiol Chem 362:1363-1367.
Inagaki T, Shikimi T F 工shinoH, Okunishi H, Takaori s (1995):
Changes in七heratio of urina工y α1-microglobulin to
ulinastatin levels in patients with Alzheimer-type and
vascular dement工a. Psych工a工y Cl工nNeurosci 49:287-290.
Jonsson-Be工工工ngB-M, Ohlsson K, Rosengren M (1989):
Radioimmunological quantitation of the u工ina工y trypsin
inhibi七orin normal blood and urine. Biol Chem Hoppe-Seyle工
370:1157-1161.
Kaumeyer JF, Polaz z工J, Kotick MP (1986): The mRNA fo工 a
protease inhibi七orrelated七o the H工-30domain of in七er-αー
trypsin inhibito工 alsoencodes α-1-microglobulin (protein HC).
Nucleic Acids Res 14:7839-7850.
Kitaguti N, Takahashi Y, Tokushima Y, Shiojiri s, Ito N (1988):
Novel p工ecursorof Alzhe工me工Ts d工seaseamylo工d protein shows
p工oteaseinhibito工Y activity ・ Natu工e (London) 331:530-532.
Ove工allJE, Gorham DR (1962): The b工iefpsychiat工ic 工atingscale.
Psychol Rep 10:799-812.
Ponte P, Gonzalez-Dewhitt P, Schilling J, Miller J, Hsu D,
G工eenbe工q B, Dav工S K, Wallace w, L工eberburg 工, FullerF,
12
... ι
Cordell B ( 1988): A new A4 amyloid mRNA. contains a domain
homologus to se工工neprote工nase工nhib工tors. Nature (London)
331:525-527.
Sapolsky R, R工V工erc, Yamamoto G, Plotsky P, Vale W (1987):
Interleukin-1 stimula七esthe secretion of hypo七halamic
corticotropin-releasing factor. Science 238:522-524 (1987)
Shikimi T, Suzuki S, Takahashi M, Kaneto H (1990): Sandwich
enzyme-immunoassay of human urina工y trypsin inhibitor
(u工inastatin) and u工工nastatin-like immunoreactive substance in
mouse urine. Scand J Clin Lab Invest 50:1- 8.
Shikimi T, Wessel T, Joh TH, Takahashi M, Kaneto H, Hattori K,
Takaori s (1993): Demonst工ationof a human u工inarytrypsin
inhibito工(urinastatin) -like substance in the murine b工ain.
Brain Res 616:230-235
Shikimi T, Himeno Y, Shigeno K, Gonda T, Ishibe T, Ha七七0工iK,
Takao工iS (1994): Relationships between ulinastatin and
alpha-1-mic工oglobulin in human urine. Clin Chim Ac七a 227:
195-200.
Smith RS (1991): The immune system is a key fac七O工 inthe
etiology of psychosoc工ald工sease. Med Hypoth 34:49-57.
Tanzi RE, Mcclatchey AI, Lampe工tiED, Villa-Koma工offL, Gusella
JF, Neve RL (1988): Protease 工nh工b工七0工 domain encoded by an
amyloid p工oteinp工ecursormRNA associated with Alzheimer『 S
disease. Nature (London) 331:528-530.
Vetr H, Gebhard W (1990): Structure of the human α1-mic工0-
globulin-bikunin gene. Biol Chem Hoppe-Seyler 371:1185-1196.
13
二 ι一一一一-==二1
Table 1. Numbe工F sex, age, levels of creatinine F α1-mic工0-
globulin (αlM) and ulinastatin (UT), and αlM/UT 工atio in u工ine
of subjects
Mood disorder
Normal Schizophrenia
Control Bipolar Depression Total
Number 18 12 10 9 19
of Subjects
Sex 10/8 6/6 5/5 5/4 10/9
( M/円
Age 40 ± 2 34 ± 3 42 ± 3 33 ± 4 38 ± 3
(years)
Cr 1.37 ± 0.16 0.97 ± 0.24 0.96士 0.17 1.37 ± 0.12 1.15 ± 0.11
(mg/ml)
α1M 6.87±0.81 6.56±0.83 9.77± 1.13 6.90± 1.21 8.41 ± 0.87
(μg/mg Cr)
UT 10.34 ± 1.33 7.75 ± 1.39 6.76 ± 1.20 5.22 ± 0.77 6.03 ± 0.73
(μg/mg Cr)
Ratio 0.75 ± 0.09 1.16士 0.21 1.65 ± 0.17a) 1.36士 0.15 1.51±0.12a)
(α1M/Uη
Values in age and urinary levels of creatinine (Cr), αlM, UT and
αlM/UT 工atio are represented as mean ± s. E .M.. Abbreviations:
n
o
F
・工
工
s
a
S
1ょ
e
O
E
PιDι
・14
e
B
d
bipolar affective disorde工; Depress工on, 工0
・1Ja
m
Superscript a)工ep工esents values (where P<0.01)
significantly different from those of cont工ols.
14
二 ι一一一==二
Con trot
ii •
,s
..... u en 10
E Cb ユ:ε
Schizophrenia
//
15
υ 白 10E Cb ユ主。5I
-
.
Mood disorder
.・〆
-
. 、
Y2 o.』,x+ 2.aJ rx: 0.67
( n:118, P<0.01)
d s
同 0.59'/ y,,, 0.95X + 2.65
ロ 0.60 (na12, P<1:l.05) (n= 19, P<D.001)
10 20 10 20 10
UT (μg/mg Cr) UT (μg/mg Cr) UT(ドダmgCr)
Fig.l. Correla七ionbe七weenurinary levels of ulina S七a七in (UT) and
α1-microglobulin (αlM) in age-ma七chedcon七rols and pa七ien七swi七h
e i七her schizophrenia or mood disorde工・s. The correl a七ion
coefficien七 and number of subjec七s are represen七edwi七h r and n
in paren七heses, respec七ively. Cr represents crea七ininein urine.
15
20
Bipolar ~ression 15「 15 . . . . 、
~ ,,.、、lo-。10υ10 ワ30) E . t ユ
. 冶) . ユ . /・。、ー” . 、、,d
2 Y= 0.76X + 4.61 .
Y=1.30X+0.11 γー・ 5 。 .
「コ 0.81「ご 0.82
(n=10, Pぐ0.01)( n=9, P<0.01)
。 。10 20 10 20
UT (μg/mg Cr) U了(μg/mgCr)
F工9・2. Correla七ionbe七weenurinary levels of ulinas七a七in (UT) and
α1-microglobulin (αlM) in pa七ien七s wi七h bipolar affec七ive
disorder (Bipolar) or major depression (Depression )・ The
correla七ioncoefficien七 and number of subjec七s are represen七ed
wi七h r and n in paren七heses, respec七iveユy.
crea七ininein urine.
16
Cr represen七S